THERALY FIBROSIS
Theraly is a preclinical-stage company whose mission is to develop innovative treatments for various forms of fibrotic disease including chronic pancreatitis, systemic sclerosis, and NASH. The company’s lead candidate, TLY012, selectively targets myofibroblasts, cells believed to be the critical originators of fibrosis, a condition that affects a variety of tissues.
THERALY FIBROSIS
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Germantown, Maryland, United States
Country:
United States
Website Url:
http://www.ddpharmatech.com
Total Employee:
11+
Status:
Active
Total Funding:
9.54 M USD
Similar Organizations
akta Pharmaceutical Development LLC
aktaPD is an international company that designs, develops, and commercializes treatments for various diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
CPSI Biotech
CPSI Biotech is an integrative bio-Medtech & healthcare firm whose mission is to develop life science research products & medical devices.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Theraly Fibrosis
Official Site Inspections
http://www.ddpharmatech.com
- Host name: 110.45.140.81
- IP address: 110.45.140.81
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
